| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/20/2007 | EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 06/20/2007 | EP1797082A1 Carbostyril compound |
| 06/20/2007 | EP1797079A1 Proline derivatives |
| 06/20/2007 | EP1797078A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
| 06/20/2007 | EP1797077A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 06/20/2007 | EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/20/2007 | EP1797075A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| 06/20/2007 | EP1797064A1 Novel compounds useful for modulating abnormal cell proliferation |
| 06/20/2007 | EP1797038A1 Thermodynamically stable form of bay 43-9006 tosylate |
| 06/20/2007 | EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof |
| 06/20/2007 | EP1796729A1 Liposomes with improved drug retention for treatment of cancer |
| 06/20/2007 | EP1796727A2 Method for the treatment of polycystic kidney disease |
| 06/20/2007 | EP1796721A1 Cancerous disease modifying antibodies |
| 06/20/2007 | EP1796691A1 Inorganic selenium for treatment of cancer |
| 06/20/2007 | EP1796689A1 Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin |
| 06/20/2007 | EP1796688A1 Pancreatic cancer treatment using na+/k+ atpase inhibitors |
| 06/20/2007 | EP1796672A1 Cancer combination therapy comprising azd2171 and imatinib |
| 06/20/2007 | EP1796670A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
| 06/20/2007 | EP1796647A2 Stable pegylated interferon formulation |
| 06/20/2007 | EP1796644A2 Drug delivery from embolic agents |
| 06/20/2007 | EP1796643A1 Treatment of androgen - deprivation induced osteoporosis |
| 06/20/2007 | EP1796537A2 Dendrimer based compositions and methods of using the same |
| 06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1373253B1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor |
| 06/20/2007 | CN1984912A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/20/2007 | CN1984909A Thiazolinone unsubstituted quinolines |
| 06/20/2007 | CN1984899A CXCR1 and CXCR2 chemokine antagonists |
| 06/20/2007 | CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| 06/20/2007 | CN1984656A Cancer treatment method |
| 06/20/2007 | CN1982455A Polynucleotide for inhibiting Wnt activity, its encoded polypeptide and use |
| 06/20/2007 | CN1982329A Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof |
| 06/20/2007 | CN1982327A Phytosterin compound and its use |
| 06/20/2007 | CN1982324A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981872A Use of PUMA in tumor chemoradiotherapy sensibilization |
| 06/20/2007 | CN1981871A Elemene externally-applied preparation and its use |
| 06/20/2007 | CN1981868A Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 06/20/2007 | CN1981860A Chinese-medicinal composition for treating chronic gastritis and atrophic gastritis and its production |
| 06/20/2007 | CN1981807A Medicinal composition for preventing and treating hepatitis and hepatocarcinoma and its production |
| 06/20/2007 | CN1981799A Preparing method for extracts of red clover |
| 06/20/2007 | CN1981785A Antineoplastic Chinese medicinal preparation |
| 06/20/2007 | CN1981776A Composition containing rare ginseng saponin, its production and usage |
| 06/20/2007 | CN1981774A Medicinal compositions |
| 06/20/2007 | CN1981773A Medicinal preparation for treating immune related diseases |
| 06/20/2007 | CN1981763A Antineoplastic usage of sinomenine and its preparation |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981755A Preparation with solid lipid nano-particle as podophyllotoxin and its derivative carrier |
| 06/20/2007 | CN1981751A Compound with P-glycoprotein inhibiting and multidrug-resisting reversing function and its salt |
| 06/20/2007 | CN1981749A Use of beta-elemene for inhibiting cerebrovascular endothelial cell |
| 06/20/2007 | CN1322135C Configuration of cell facter IL-24 eucargon expression carrier and application |
| 06/20/2007 | CN1322114C Anti-tumor and antiviral medicine and production method thereof |
| 06/20/2007 | CN1322014C Gecko polysaccharide, and its preparing method and pharmaceutical use |
| 06/20/2007 | CN1322011C Chain antibiotics / granul cell-macrophage colong stimulating factor fusion protein |
| 06/20/2007 | CN1322005C Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 06/20/2007 | CN1322001C Novel compounds that inhibit factor Xa activity |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/20/2007 | CN1321961C New method for picking-up purified resveratrol from giant knotweed |
| 06/20/2007 | CN1321696C Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321684C Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321670C Chinese traditional medicine preparation for curing tumour and process for preparing the same |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321636C Use of chrysophanic acid in inhibiting vascularization |
| 06/19/2007 | US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232901 For preparing 2,4-disubstituted pyrrolotriazine compounds |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232843 Compositions containing C-substituted diindolylmethane compounds |
| 06/19/2007 | US7232838 2-amino-4,5-trisubstituted thiazolyl derivatives |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232816 Phosphodiesterase inhibitors; used to treat inflammatory conditions, allergies such as rhinitis, respiratory system disorders and cancer |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232806 Small temporal RNA rannging from 21 and 22 base pairs for use regulatory modulators of gene expression; treatment and prevention of cell proliferative disorders |
| 06/19/2007 | US7232682 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/19/2007 | US7232653 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2352515C Methods for identifying combinations of entities as therapeutics |
| 06/19/2007 | CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 06/19/2007 | CA2271940C Novel phenanthridinium derivatives |
| 06/19/2007 | CA2189690C Novel active peptide and its preparation |
| 06/16/2007 | CA2557055A1 Peptides for stimulating an immune response against melanoma |
| 06/14/2007 | WO2007067994A1 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | WO2007067993A1 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | WO2007067781A2 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| 06/14/2007 | WO2007067602A1 Interleukin-11 compositions and methods of use |
| 06/14/2007 | WO2007067565A1 Process for the preparation of purified crystalline cci-779 |